Form 4: Stryker Group President Granted Stock Options

Stryker's Group President, Dylan Bram Crotty, was granted 9,978 employee stock options with an exercise price of $360.82.

Summary

• Dylan Bram Crotty, Group President of Stryker Corp (SYK), was granted 9,978 employee stock options.
• The options were granted on February 4, 2026, with an exercise price of $360.82 per share.
• These options are exercisable as to 20% on each of the first five anniversaries of the grant date.
• The options expire on February 3, 2036.
• The grant was made pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine executive compensation event, aligning management incentives with shareholder interests, which is generally positive for corporate governance and long-term company performance.

Positives

• The grant of stock options aligns the interests of Group President Dylan Bram Crotty with long-term shareholder value.
• The options were granted at a price of $0, indicating they are part of a compensation package designed to incentivize future performance.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the vesting schedule of the granted options.

Industry Context

StockSavvy.ai notes that stock option grants are a common form of executive compensation in the medical technology industry, designed to align executive interests with long-term shareholder value and encourage retention. This practice is standard across many sectors for incentivizing leadership.

Comparison to Industry Standards

• Stock option grants with multi-year vesting schedules are a standard component of executive compensation packages across various industries, including medical devices.
• Companies such as Medtronic (MDT) and Johnson & Johnson (JNJ), key competitors in the medical technology space, also utilize similar long-term incentive plans for their executives.
• The vesting schedule of 20% annually over five years is typical for encouraging long-term commitment and performance, aligning with best practices in corporate governance for executive incentives.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential benefit from increased alignment of executive interests with long-term company performance and value creation.
• Employees: The grant is part of an executive compensation plan, which can set a precedent for performance-based incentives within the company.

Next Steps

• The granted options will vest at a rate of 20% on each of the first five anniversaries of the February 4, 2026 grant date.

Key Dates

Recommendation

This Form 4 reports a routine grant of stock options to a key executive as part of their compensation package. While it aligns management's interests with long-term shareholder value, it does not provide new fundamental information to warrant a change in investment recommendation based solely on this filing.

Keywords

Stryker, SYK, Stock Option, Insider Transaction, Executive Compensation, Form 4, Dylan Bram Crotty